Showing results (31-40 of 216) with videos related to
Sort By:
Pageof 22
Journal of Clinical Pharmacology|December 15, 2017
Pharmacokinetics of Osimertinib in Chinese Patients With Advanced NSCLC: A Phase 1 StudyHongyun Zhao, Junning Cao, Jianhua Chang, et al.Journal of Cancer|June 18, 2019
Comparison of the Prognostic Value of Systemic Inflammation Response Markers in Small Cell Lung Cancer PatientsTing Zhou, Yuanyang Zhao, Shen Zhao, et al.Cancer Cell International|August 29, 2021
Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytesFan Luo, Jiaxin Cao, Feiteng Lu, et al.Journal of Clinical and Translational Hepatology|October 15, 2025
Portal Vein Thrombosis in Liver Cirrhosis: A Review of Risk Factors and Predictive IndicatorsZhicheng Yang, Yongle Zhao, Honglin Chen, et al.ACS Applied Materials & Interfaces|January 24, 2025
The P2X7-Mediated Mitochondrial ROS as an Emerging Core Target of Tuftsin Nanoparticles in Severe Acute Pancreatitis Therapy via Regulating MitophagyE Wen, Yu Tian, Mingxiao Fang, et al.Nutrition and Cancer|June 1, 2022
Predictive Value of High Preoperative Serum Total Protein and Elevated Hematocrit in Patients with Non-Small-Cell Lung Cancer after Radical ResectionJiaxin Cao, Fan Luo, Kangmei Zeng, et al.Biomedical Chromatography : BMC|October 20, 2019
Development of an LC-MS/MS method for quantifying two main metabolites of abivertinib in human plasmaXin Zheng, Weicong Wang, Yanbao Zhang, et al.Nano Letters|February 9, 2018
Peptide-Functionalized Phase-Transformation Nanoparticles for Low Intensity Focused Ultrasound-Assisted Tumor Imaging and TherapyLeiLei Zhu, HongYun Zhao, ZhiYi Zhou, et al.Oncotarget|April 21, 2016
Alcohol and survival in ESCC: prediagnosis alcohol consumption and postoperative survival in lymph node-negative esophageal carcinoma patientsQilong Ma, Wengao Liu, Ran Jia, et al.Cancer Treatment and Research Communications|May 19, 2026
Prognostic value of chemotherapy-related mean corpuscular hemoglobin (MCH) kinetics in patients with non-small cell lung cancer receiving adjuvant chemotherapyJiaxin Cao, Qun Chen, Ting Yang, et al.Pageof 22